No Material Adverse Change has occurred Sample Clauses

No Material Adverse Change has occurred. 6. The undersigned is a Responsible Officer. [Balance of Page Intentionally Left Blank]
AutoNDA by SimpleDocs
No Material Adverse Change has occurred. 6. The undersigned is a Responsible Officer.
No Material Adverse Change has occurred. 6. The proceeds for Growth Capital Advance shall be disbursed as follows: Disbursement from Lender: Growth Capital Advance Amount $5,000,000.00 Less: Legal Fees and costs ($89,612.73) Balance of Facility Fee $0.00 Net proceeds due from Lender to Borrower: $4,910,387.27
No Material Adverse Change has occurred. 6. The proceeds for the Term Loan shall be disbursed as follows: Disbursement from Collateral Agent: Loan Amount $15,000,000 Less: Lender’s Legal Fees ($ ) Balance of Facility Fee $ N/A Net Proceeds due from Collateral Agent: $ The aggregate net proceeds of the Term Loan in the amount of $ shall be transferred to Borrower’s account as follows: Account Name: Bank Name: Bank Address: Account Number: ABA Number: Dated: , 2010 BORROWER: MEDICINOVA, INC. By Name: Title: GUARANTOR: AVIGEN, INC. By Name: Title: AS COLLATERAL AGENT AND AS A LENDER: OXFORD FINANCE CORPORATION By Name: Title: EXHIBIT C COMPLIANCE CERTIFICATE TO: OXFORD FINANCE CORPORATION, as Collateral Agent Date: FROM: MEDICINOVA, INC. The undersigned authorized officer of MEDICINOVA, INC. hereby certifies that in accordance with the terms and conditions of the Loan and Security Agreement between Borrower, Guarantor, and Lender (the “Agreement”),
No Material Adverse Change has occurred. 6. The proceeds for the Term Loan shall be disbursed as follows: Disbursement from Oxford: Loan Amount $ 8,000,000 —Deposit Received Less: —Existing Debt Payoff —Oxford's Legal Fees —Oxford's Facility Fee Net Proceeds due from Oxford: $ $ $ Disbursement from Horizon: Loan Amount $ 5,000,000 —Deposit Received Less: —Existing Debt Payoff —Horizon's Legal Fees —Horizon's Facility Fee Net Proceeds due from Horizon: $ $ $ The aggregate net proceeds of the Term Loan in the amount of $ shall be transferred to Borrower's account as follows: Account Name: Bank Name: Bank Address: Account Number: ABA Number: Dated: September , 2010 BORROWER: TRANZYME, INC. By Name: Title: TRANZYME PHARMA INC. By Name: Title: LENDERS AND COLLATERAL AGENT: OXFORD FINANCE CORPORATION, as Collateral Agent and as a Lender By Name: Title: COMPASS HORIZON FUNDING COMPANY LLC, as a Lender By Name: Title: TO: Oxford Finance Corporation, as Collateral Agent FROM: Tranzyme, Inc. and Tranzyme Pharma Inc. The undersigned authorized officer of TRANZYME, INC., a Delaware corporation ("Tranzyme"), and TRANZYME PHARMA INC., a Canadian corporation ("Tranzyme-Canada") (Tranzyme and Tranzyme-Canada are referred to herein individually and collectively, jointly and severally, solidarily, as "Borrower") hereby certifies that in accordance with the terms and conditions of the Loan and Security Agreement among Borrower, Collateral Agent, and the Lenders (the "Agreement"),

Related to No Material Adverse Change has occurred

  • No Material Adverse Change No event or condition of a type described in Section 3(h) hereof shall have occurred or shall exist, which event or condition is not described in the Pricing Disclosure Package (excluding any amendment or supplement thereto) and the Prospectus (excluding any amendment or supplement thereto) and the effect of which in the judgment of the Representatives makes it impracticable or inadvisable to proceed with the offering, sale or delivery of the Shares on the Closing Date or the Additional Closing Date, as the case may be, on the terms and in the manner contemplated by this Agreement, the Pricing Disclosure Package and the Prospectus.

  • No Material Adverse Changes Since the respective dates as of which information is given in the Registration Statement and the Prospectus, except as set forth in the Registration Statement, the General Disclosure Package and the Prospectus (i) there shall not have been a Material Adverse Change, (ii) the Company shall not have incurred any material liabilities or obligations, direct or contingent, (iii) the Company shall not have entered into any material transactions not in the ordinary course of business other than pursuant to this Agreement and the transactions referred to herein, (iv) the Company shall not have issued any securities (other than the Securities or the Shares issued in the ordinary course of business pursuant to existing employee benefit plans of the Company referred to in the Registration Statement, General Disclosure Package and the Prospectus) or declared or paid any dividend or made any distribution in respect of its capital stock of any class or debt (long-term or short-term), and (v) no material amount of the assets of the Company shall have been pledged, mortgaged or otherwise encumbered.

  • No Material Adverse Change in Business Except as otherwise stated therein, since the respective dates as of which information is given in the Registration Statement, the General Disclosure Package or the Prospectus, (A) there has been no material adverse change in the condition, financial or otherwise, or in the earnings, business affairs or business prospects of the Company and its subsidiaries considered as one enterprise, whether or not arising in the ordinary course of business (a “Material Adverse Effect”), (B) there have been no transactions entered into by the Company or any of its subsidiaries, other than those in the ordinary course of business, which are material with respect to the Company and its subsidiaries considered as one enterprise, and (C) there has been no dividend or distribution of any kind declared, paid or made by the Company on any class of its capital stock.

  • No Material Adverse Effects At Closing Time, there shall not have been, since the date hereof or since the respective dates as of which information is given in the Prospectus or the General Disclosure Package, any Material Adverse Effect.

  • No Material Adverse Effect Since the date of this Agreement, there shall not have occurred any Material Adverse Effect.

  • Financial Condition; No Material Adverse Change (a) The Borrower has heretofore furnished to the Lenders its consolidated balance sheet and statements of income, stockholders equity and cash flows (i) as of and for the fiscal year ended December 31, 2013 reported on by Ernst & Young, independent public accountants, and (ii) as of and for the fiscal quarter and the portion of the fiscal year ended June 30, 2014, certified by its chief financial officer. Such financial statements present fairly, in all material respects, the financial position and results of operations and cash flows of the Borrower and its consolidated Subsidiaries as of such dates and for such periods in accordance with GAAP, subject to year-end audit adjustments and the absence of footnotes in the case of the statements referred to in clause (ii) above.

  • No Material Adverse Change in Financial Statements All consolidated and consolidating financial statements related to Borrower and any Subsidiary that are delivered by Borrower to Bank fairly present in all material respects Borrower’s consolidated and consolidating financial condition as of the date thereof and Borrower’s consolidated and consolidating results of operations for the period then ended. There has not been a material adverse change in the consolidated or in the consolidating financial condition of Borrower since the date of the most recent of such financial statements submitted to Bank.

  • No Material Adverse Event Since the respective dates as of which information is disclosed in the Registration Statement, the Prospectus and the Incorporated Documents, except as otherwise stated therein, there shall not have been (i) any change or decrease in previously reported results specified in the letter or letters referred to in paragraph (d) of this Section 6 or (ii) any change, or any development involving a prospective change, in or affecting the condition (financial or otherwise), earnings, business or properties of the Company and its subsidiaries taken as a whole, whether or not arising from transactions in the ordinary course of business, except as set forth in or contemplated in the Registration Statement, the Prospectus and the Incorporated Documents (exclusive of any amendment or supplement thereto) the effect of which, in any case referred to in clause (i) or (ii) above, is, in the sole judgment of the Manager, so material and adverse as to make it impractical or inadvisable to proceed with the offering or delivery of the Shares as contemplated by the Registration Statement (exclusive of any amendment thereof), the Incorporated Documents and the Prospectus (exclusive of any amendment or supplement thereto).

  • Financial Statements; No Material Adverse Change All financial statements relating to Borrower which have been or may hereafter be delivered by Borrower to Lender have been prepared in accordance with GAAP and fairly present the financial condition and the results of operation of Borrower as at the dates and for the periods set forth therein. Except as disclosed in any interim financial statements furnished by Borrower to Lender prior to the date of this Agreement, there has been no material adverse change in the assets, liabilities, properties and condition, financial or otherwise, of Borrower, since the date of the most recent audited financial statements furnished by Borrower to Lender prior to the date of this Agreement.

  • Material Adverse Change A Material Adverse Change occurs;

Time is Money Join Law Insider Premium to draft better contracts faster.